$5.94
0.040.68%
Last update: Nov 9, 3:06 PM

Eikon Therapeutics (EIKN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-1.49 | $-4.07 | $-1.58 |
| Actual | $-1.63 | $-2.46 | $-1.48 |
| Surprise | -9.40% | +39.6% | +6.33% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | — | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.63 | $-1.67 | $-1.85 | $-1.90 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-1.63 | $-1.49 | -9.40 % |
| Q1 | May 11, 2026 | $-2.46 | $-4.07 | 39.6 % |
| Q4 | Mar 30, 2026 | $-1.48 | $-1.58 | 6.33 % |